ASSOCIATION OF HISTOLOGIC MEASUREMENT WITH ENDOSCOPIC OUTCOMES AFTER ONE YEAR OF TREATMENT WITH MIRIKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE
Fernando Magro 1
Gert De Hertogh 2
Marijana Protic 3
Lai Shan Chan 3
Paul Pollack 3
Brian G. Feagan 4
Noam Harpaz 5
Rish Pai 6
Walter Reinisch 7
1 University Hospital São João, Porto, Portugal
2 University Hospital Leuven, Leuven, Belgium
3 Eli Lilly and Company, Indianapolis, United States
4 Robarts Clinical Trials Inc., London, Canada
5 Icahn School of Medicine at Mount Sinai, New York City, United States
6 Mayo Clinic, Scottdale, United States
7 Medical University of Vienna, Wien, Austria
Session
IBD (Posters)
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]